Sarepta Therapeutics
Price & Volume
Stats
See more52W Range | $14.68-$25.32 |
Market Cap | $2.2B |
Shares Short | 27M |
Financials
See moreRevenue (12 Mos) | $1.9B |
Revenue Growth (YoY) | -34.3% |
Gross Profit (12 Mos) | -$341.5M |
Diluted EPS | -$1.57 |
News
See moreYahoo Finance • 3 days ago
Moderna Stock Carries A Market Value Its Revenue Does Not Support
Yahoo Finance • 5 days ago
Why Regenxbio Halted Its Gene Therapy Trial—and Why the Stock Is Tumbling
Yahoo Finance • 24 days ago
Sarepta forecasts $1.2B-$1.3B 2026 net product revenue as Cohort 8 12-week data shifts to Q1 2027
Yahoo Finance • 24 days ago
Arrowhead Pharmaceuticals Inc (ARWR) (Q3 2026) Earnings Call Highlights: Strong Phase III Data ...
About
CEO | Dr. Michael E. Severino M.D. |
CFO | Mr. Ryan H. Wong |
Address | 215 First Street, Cambridge, MA, United States, 02142 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 835 |